SINTX Technologies Inc
NASDAQ:SINT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SINTX Technologies Inc
Pre-Tax Income
SINTX Technologies Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SINTX Technologies Inc
NASDAQ:SINT
|
Pre-Tax Income
-$9.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Pre-Tax Income
$3.7B
|
CAGR 3-Years
38%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Pre-Tax Income
$1.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Pre-Tax Income
$4.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Pre-Tax Income
$8.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Pre-Tax Income
$3.3B
|
CAGR 3-Years
27%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
SINTX Technologies Inc
Glance View
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 36 full-time employees. The company went IPO on 2014-02-11. The firm is focused on manufacturing, research and development of silicon nitride ceramics for external partners. The firm's medical-grade silicon nitride products includes FleX SN-MC2, FleX SN-CSC, FleX SN-PEEK and FleX SN-AP, which are biocompatible, bioactive, antipathogenic and has a bone affinity. The firm's antipathogenic product, FleX SN-AP, which is a silicon nitride antipathogenic powder used in manufacturing of products such as face masks and personal protective equipment. The firm's non-medical applications are used in manufacturing of ceramic armors for the aerospace and defense industries. Its industrial silicon nitride has a combination of mechanical, thermal and electrical properties of any technical ceramic material.
See Also
What is SINTX Technologies Inc's Pre-Tax Income?
Pre-Tax Income
-9.8m
USD
Based on the financial report for Sep 30, 2025, SINTX Technologies Inc's Pre-Tax Income amounts to -9.8m USD.
What is SINTX Technologies Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
11%
Over the last year, the Pre-Tax Income growth was 16%. The average annual Pre-Tax Income growth rates for SINTX Technologies Inc have been 1% over the past three years , -9% over the past five years , and 11% over the past ten years .
